Seminars in Oncology Nursing最新文献

{"title":"Measuring and Responding to What Matters in Patient Reported Outcomes: The What and the Why.","authors":"Doris Howell","doi":"10.1016/j.soncn.2025.151942","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151942","url":null,"abstract":"<p><strong>Objectives: </strong>To discuss challenges in Patient Reported Outcome Symptom Screening in routine cancer care and the importance of personalized symptom management and patient involvement in care.</p><p><strong>Methods: </strong>In this paper, the extant literature on routine symptom screening and monitoring in cancer care using Patient-Reported Outcome Measures is examined. This paper expands on ideas from a presentation given at the inaugural meeting of the Global Alliance for Symptom Science in Lausanne Switzerland, 2023. Ongoing challenges in measuring and responding effectively to \"what matters\" in routine screening to reduce symptom burden and quality of life is discussed.</p><p><strong>Results: </strong>This paper provides a discussion based on key literature to identify key challenges that must be addressed for symptom screening to reduce symptom burden and improve quality of life and potential solutions as follows: (1) measuring what matters from the perspective of the person, (2) responding effectively to screening data from the lens of person-centered care, (3) measuring meaningful symptom improvement and health outcomes from the perspective of patients, and (4) engaging patients (and families) in self-management as co-contributors of symptom and health outcomes.</p><p><strong>Conclusion: </strong>Patient reported outcomes can improve personalized symptom care, however a quality response to symptom data is essential.</p><p><strong>Implications for nurses: </strong>Nurses have long been identified as the cornerstone to effective symptom management; and they play a vital role in promoting a person-centered approach to PROs data and responding to 'what matters' to the person in the context of their daily life. Upskilling of nurses in self-management health coaching will be critical to building patient capacity as co-contributors to health outcomes.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151942"},"PeriodicalIF":2.3,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144621179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors Associated with Immune Effector Cell-Associated Neurotoxicity Syndrome in Adults with Hematological Malignancies Undergoing Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review.","authors":"Silvia Belloni, Chiara Giacon, Arianna Magon, Daniele Girardi, Marco Alfredo Arcidiacono, Greta Ghizzardi, Gianluca Conte, Rosario Caruso, Cristina Arrigoni","doi":"10.1016/j.soncn.2025.151944","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151944","url":null,"abstract":"<p><strong>Objectives: </strong>We systematically appraised studies investigating factors associated with ICANS development after CAR-T cell therapies in adults with hematological malignancies and estimated ICANS prevalence.</p><p><strong>Method: </strong>We conducted a systematic review (SR) in 4 databases following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for studies published from 2010 to December 2024. We estimated ICANS prevalence with exact binomial and score test-based 95% confidence intervals. We applied the Freeman-Tukey double arcsine transformation to stabilize variances within random-effects models using the Metaprop command in Stata.</p><p><strong>Results: </strong>Sixteen studies (14 retrospective, n = 135, and 2 prospective, n = 300) were included in this SR. The sample comprised adults with various hematological malignancies who received anti-CD19 anti-BCMA. Some clinical factors seem to be associated with ICANS incidence and severity. In retrospective studies, the pooled prevalence was 41% (95% CI: 31%-51%) for all grades of ICANS and 20% (95% CI: 13%-28%) for grade ≥3 ICANS. In prospective studies, the pooled prevalence was 51% (95% CI: 45%-56%).</p><p><strong>Conclusions: </strong>Approximately half of hematological patients undergoing CAR T therapy develop ICANS. Although some factors may contribute to the development of ICANS, limited studies and samples, the retrospective nature of the majority of studies, and the discordance among the results preclude certain risk factors conclusions.</p><p><strong>Implications for nursing practice: </strong>Nurses play a pivotal role in post-treatment monitoring in the early detection and management of ICANS, given their direct and continuous patient interaction. Increasing nurses' awareness of potential risk factors for ICANS can enhance their vigilance and effectiveness in managing this condition.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151944"},"PeriodicalIF":2.3,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Measurement of Patient-Reported Outcomes: The How, When, and Where.","authors":"Jo Armes","doi":"10.1016/j.soncn.2025.151941","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151941","url":null,"abstract":"<p><strong>Objectives: </strong>There is growing evidence that integrating patient-reported outcomes (PRO) into clinical assessments is associated with improved symptom management, patient satisfaction, and survival rates. This report aims to critically examine factors that influence how, when, and where PRO should be assessed in the cancer pathway.</p><p><strong>Methods: </strong>This discussion is grounded in clinical research expertise and supported by relevant literature from peer-reviewed journals.</p><p><strong>Results: </strong>Multiple digital methods for conducting PRO assessments are being used. Evidence increasingly suggests that adopting a hybrid approach is more likely to ensure that diverse populations complete PRO assessments. This will ensure the data generated are more representative of the wider cancer population. Most research focuses on assessing PRO during treatment while less focuses on the postsurgical and survivorship phases in the cancer pathway. During treatment, more frequent PRO assessment is more informative and better able to guide clinical decision-making. This, however, needs to be balanced against respondent burden. Matching the method for capturing PRO assessment to the preferences and requirements of respondents may be more important than the location in which it occurs.</p><p><strong>Conclusion: </strong>Regular assessment of PRO improves patient outcomes during treatment and, based on the limited evidence available, following surgery and during the survivorship phase of the cancer pathway.</p><p><strong>Implications for nursing practice: </strong>More research is needed to identify the optimal timing of PRO assessments during treatment to maximize information while minimizing respondent burden. Finally, we need to better understand which methods for capturing PRO assessments best meet the diverse personal requirements and preferences of the wider cancer population.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151941"},"PeriodicalIF":2.3,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144568071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and Validation of a Patient-Reported Outcome Measure to Assess the Impact of Steroids in the Treatment of Myeloma: The Steroid Symptom Questionnaire-Multiple Myeloma.","authors":"Tracy King, Louise Acret, Claudia Rutherford, Margaret-Ann Tait, Jacqueline Jagger, Julija Sipavicius, Georgia McCaughan, Douglas Joshua, Kate White","doi":"10.1016/j.soncn.2025.151943","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151943","url":null,"abstract":"<p><strong>Objectives: </strong>Steroids routinely used in the treatment of multiple myeloma (MM) are associated with adverse effects affecting health-related quality of life (HRQoL). No assessment tool existed to measure the impact of steroids in this population. We developed and psychometrically evaluated the Steroid Symptom Questionnaire-Multiple Myeloma (SSQ-MM).</p><p><strong>Methods: </strong>A conceptual framework for steroid-related PROs was developed through a systematic review and qualitative interviews. An existing tool was adapted and pretested with patients (n = 5), carers (n = 3), and clinicians (n = 9) for relevance and face validity. In field test 1, the draft-SSQ-MM was administered to 70 patients. Items were chosen based on item-level analysis for acceptability. In Field Test 2, the psychometric properties of the final SSQ-MM were assessed in 140 patients as part of a multicenter study. The SSQ-MM was administered alongside the EORTC QLQ-C30 and MY20, with the SSQ-MM administered again 1 week later.</p><p><strong>Results: </strong>The SSQ-MM contains 20 items. Stability reliability was supported (ICC = 0.846), and item-total correlations ranged between 0.266 and 0.677, excluding hiccups and blood glucose, which were retained due to clinical relevance. Exploratory factor analysis supported a total score and four multi-item subscales with acceptable internal consistency (α = 0.64 to 0.82). We found evidence of convergent and divergent validity between scales measuring similar and dissimilar constructs on QLQ-C30. The SSQ-MM total score was able to differentiate between patient groups clinically known to differ.</p><p><strong>Conclusions: </strong>The SSQ-MM provides a validated PROM for use in research and clinical settings to assess the impact of steroids and identify those who may benefit from dose reduction to improve PROs, including HRQoL.</p><p><strong>Implications for nursing practice: </strong>Integrating assessment of steroid adverse effects using the SSQ-MM into routine nursing care can help direct timely interventions or referrals to assist patients better manage the emotional and behavioural effects of steroids. Dose optimisation may reduce steroid effects and improve HRQoL.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151943"},"PeriodicalIF":2.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pilot Testing an Adapted Version of the Registered Nursing Forecasting (RN4CAST) Nurse Survey in Systemic Anti-Cancer Therapy Day Units: A Mixed-Methods Feasibility Study.","authors":"Zhuming Bao, Jenny Harris, Anne Marie Rafferty, Verna Lavender, Amparo Domingo Lacasa, Emma Masters, Hayley Beer, Katy Tait, Rhona Johnson, Jo Armes","doi":"10.1016/j.soncn.2025.151940","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151940","url":null,"abstract":"<p><strong>Objectives: </strong>Systemic Anti-Cancer Therapy (SACT) day units are increasingly challenged by workload pressures and workforce shortages. The Registered Nursing Forecasting (RN4CAST) survey, originally developed to predict workforce needs in acute and geriatric inpatient units, was adapted to create the RN4CAST-SACT-D survey specifically for SACT day units. This study aimed to pilot test and evaluate the feasibility of the adapted RN4CAST-SACT-D survey.</p><p><strong>Methods: </strong>A convergent mixed-methods feasibility study was conducted, incorporating an embedded qualitative component through semi-structured interviews. Five SACT day units were invited to participate, with all nurses working on the designated census day invited to complete the RN4CAST-SACT-D survey, followed by a semi-structured interview. Additionally, patients attending for chemotherapy on the census day were invited to complete the Patient-Reported Chemotherapy Indicators of Symptoms and Experience (PR-CISE) survey.</p><p><strong>Results: </strong>A total of 43 nurses completed the RN4CAST-SACT-D survey, yielding a response rate of 69.3%. Of these, 12 nurses participated in semi-structured interviews. Additionally, 172 patients completed the PR-CISE survey, with a response rate of 50%. The study identified key challenges and provided recommendations to refine the survey methodology, informed by both survey responses and interview insights.</p><p><strong>Conclusion: </strong>The findings suggest that the RN4CAST-SACT-D survey is a feasible tool for assessing workforce-related factors in SACT day units. While the survey methodology was generally well-received, certain aspects require further refinement and testing to enhance its applicability and effectiveness.</p><p><strong>Implications for nursing practice: </strong>This study highlighted that current staffing levels in SACT day units are largely based on historical data, rather than on present-day needs. This underscores the urgent need for research specifically focused on SACT day unit settings.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151940"},"PeriodicalIF":2.3,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Symptom Science in Pediatric Oncology.","authors":"Sue Zupanec, Kathleen E Montgomery, Pamela S Hinds","doi":"10.1016/j.soncn.2025.151902","DOIUrl":"10.1016/j.soncn.2025.151902","url":null,"abstract":"<p><strong>Objectives: </strong>to describe the historical evolution of symptom science in pediatric oncology from single symptom measurement to standardizing patient- and caregiver-reported outcomes in clinical trials, including underlying theoretical guidance, contributions of advanced analytics, and the state of integration of the science into clinical practice. Developmental considerations are also described.</p><p><strong>Methods: </strong>historical and current peer-reviewed literature including original research reports and reviews as well as clinical practice guidelines were reviewed and findings extracted.</p><p><strong>Results: </strong>Standardized patient-, caregiver-, and clinician-reported symptom and treatment toxicity outcomes are now embedded in certain clinical trials of the largest pediatric oncology cooperative group. Though the 3 reports can be discordant, findings indicate the willingness of patients, caregivers and clinicians to report on symptoms and toxicities. Concurrently, advanced analytics have revealed the existence of patient subgroups in terms of symptom experiences. This latter finding combined with the use of estimated minimally important differences, makes possible the potential of tailoring symptom management. Embedding symptom reports in clinical practice in a standardized manner, including real time reports and care, is a future milestone in pediatric oncology symptom science.</p><p><strong>Conclusions: </strong>Three symptom perspectives, the patient, family caregiver, and clinician, are essential to accurately measure and manage the impact of cancer therapies on patient symptoms, treatment tolerability, function, and quality of life.</p><p><strong>Implications for nursing practice: </strong>Standardizing patient, family, and clinician reports will provide important research and clinical care advances. Embedding these 3 perspectives in nursing practice in a standardized approach is the next milestone for symptom science in pediatric oncology.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151902"},"PeriodicalIF":2.3,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144337260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"\"It Is Kind of Invisible Work\": Lived Experiences of Informal Caregivers of People with a Brain Tumor.","authors":"Anna Zanotto, Chris McVittie, Karen Goodall, Marion Ellison","doi":"10.1016/j.soncn.2025.151938","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151938","url":null,"abstract":"<p><strong>Objectives: </strong>Primary brain tumor presents symptoms related to both cancer and neurological condition. Due to unique characteristics and related care demands, neuro-oncology family caregivers experience different challenges compared to family members of other cancer survivors. The purpose of this study was to understand the informal caregivers' lived experiences of coping, support needs, and changes in relationships while caring for family member or friend with a brain tumor.</p><p><strong>Methods: </strong>In-depth interviews were conducted with 10 informal caregivers of people diagnosed with a primary brain tumor. The mean age of participants was 45 years (range 19-68 years), and 90% of participants were female (n = 9). Time since diagnosis of the family member ranged from 1 month to 13 years (mean = 4 years). Interviews were transcribed verbatim and analyzed using Interpretative Phenomenological Analysis.</p><p><strong>Results: </strong>Five interrelated themes were identified following the analysis: (1) Exhaustion and all-consuming role, (2) experiencing rupture and loss, (3) togetherness and isolation, (4) navigating healthcare and lack of support, and (5) anticipating grief. There was an overarching sense of loneliness, loss on multiple levels, and feeling invisible in their caregiving role.</p><p><strong>Conclusion: </strong>Neuro-oncology caregiving was described as an extremely challenging and lonely experience. The current findings support calls for healthcare services redesign which would provide family-based cancer care.</p><p><strong>Implications for nursing practice: </strong>Findings highlight the importance of involving informal caregivers of persons with a brain tumor in the treatment process and their important role be acknowledged.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151938"},"PeriodicalIF":2.3,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144287129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Cost-Effectiveness of Nursing Interventions in Cancer Care: Systematic Review.","authors":"İlknur Yazıcıoğlu, Gülcan Bağçivan, Anica Kolic","doi":"10.1016/j.soncn.2025.151907","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151907","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to comprehensively examine the studies evaluating the cost impact of nursing intervention in cancer care.</p><p><strong>Methods: </strong>PubMed, Scopus, Web of Science, MEDLINE, Cochrane Library, and CINAHL were searched between 2001 and 2024 for randomized controlled trials examining the cost-effectiveness of nursing intervention in cancer care. The search strategy and selection process was done following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Studies were included if they (1) involved nursing intervention (nurse-led or nurse involved), (2) were conducted with adult patients with cancer, (3) reported cost-effectiveness outcome, and (4) were randomized controlled trials. The study selection process was performed on the Rayyan program. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist was used for quality assessment of included studies.</p><p><strong>Results: </strong>Twenty-four studies met the criteria and were analyzed. More than half of the studies (18/24) were classified as moderate quality. The types of interventions were nursing care including follow-ups, home visits and needs assessment (n = 11, 46%), education program (n = 2, 8%), telephone follow-up (n = 6, 25%), psychosocial support (n = 1, 4%), group medical consultations (n = 1, 4%), and Geriatric Assessment Management (n = 1, 4%). Seventeen of the interventions were led by the nurse and five were performed by the health care team including a nurse.</p><p><strong>Conclusions: </strong>In this systematic review, many of the included studies showed the cost-reducing effect of nurse care. Cost-effectiveness can be demonstrated as a way to convince health care system decision-makers to integrate an intervention into care services; in this respect, this result is significant.</p><p><strong>Implications for nursing practice: </strong>Nurses are one of the key factors in the structure of health care delivery, including financing, cost-effectiveness, and resource management. In terms of cancer care, considering the high treatment costs in the world, there is a need to make the situation cost-effective. As providers of health care services, nurses should provide evidence of cost-reducing interventions.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151907"},"PeriodicalIF":2.3,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Use of Virtual Reality as an Innovative Intervention for Managing Anxiety in Chemotherapy Patients: A Systematic Literature Review.","authors":"Giorgia Gaudino, Ettore Palma, Sergio Ferrante, Diego Lopane, Chiara Coldani, Daniela Cattani, Alessandra Dacomi, Giuseppina Tomaiuolo, Stefano Mancin, Beatrice Mazzoleni","doi":"10.1016/j.soncn.2025.151908","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151908","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the effectiveness of immersive virtual reality (VR) as an innovative non-pharmacological intervention to reduce anxiety and alleviate emotional distress in cancer patients undergoing chemotherapy.</p><p><strong>Methods: </strong>A systematic literature review was conducted between March and May 2024 across PubMed, CINAHL, Embase, Scopus, and MedRxiv databases, following PRISMA guidelines. The review included studies on immersive and non-immersive VR interventions in chemotherapy settings. Methodological quality was assessed using the Joanna Briggs Institute tools, and the certainty of evidence was evaluated through the Oxford Centre for Evidence-Based Medicine framework.</p><p><strong>Results: </strong>Seven studies involving a total of 594 participants were included. Across all studies, VR interventions significantly reduced anxiety levels during chemotherapy (P < .05). Immersive VR consistently functioned as a distraction tool, offering relaxation and emotional relief.</p><p><strong>Conclusions: </strong>Immersive virtual reality appears to be an effective and safe complementary intervention to reduce anxiety in oncology patients undergoing chemotherapy. Despite promising findings, further high-quality research is needed to confirm these results and assess long-term effects.</p><p><strong>Implications for nursing practice: </strong>VR can be integrated into clinical nursing practice as an innovative, non-invasive strategy to enhance the emotional well-being of patients receiving chemotherapy. Nurses should receive appropriate training to administer VR interventions and contribute to multidisciplinary efforts in supportive cancer care.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151908"},"PeriodicalIF":2.3,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144227633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cancer Care for Refugees in Türkiye: Challenges and Achievements","authors":"Seda Güney ,&nbsp;Özlem Çiçek Doğan ,&nbsp;Gülcan Bağçivan","doi":"10.1016/j.soncn.2025.151879","DOIUrl":"10.1016/j.soncn.2025.151879","url":null,"abstract":"<div><h3>Objectives</h3><div>In Türkiye, which hosts over 3.6 million Syrian refugees seeking safety and stability, reducing inequalities in access to adequate cancer care is pivotal and multifaceted. This study aims to critically discuss cancer care provided for refugees in Türkiye, focusing on the barriers they face, and the progress in addressing these challenges.</div></div><div><h3>Method</h3><div>This discussion paper employs an environmental scan approach. Literature searches in both English and Turkish were conducted using databases Web of Science, PubMed, TR Dizin, and MEDLINE, focusing on keywords such as “refugees,” “cancer care,” and “immigrants.” Policy documents and regulations related to refugee health in Türkiye were also reviewed. The analysis incorporated information from official websites and online resources, including the Turkish Ministry of Health (MoH), Directorate General of Migration Management (DGMM), World Health Organization (WHO)United Nations High Commissioner for Refugees (UNHCR), United Nations Development Program (UNDP), and reports from the EU-funded SIHHAT Project. The Conceptual Framework for Health Service Use was utilized to structure the reporting and analysis of the literature, ensuring a comprehensive assessment of access to cancer care among refugees.</div></div><div><h3>Results</h3><div>Findings reveal multiple factors influence refugees' access to cancer care in Türkiye. Predisposing factors, such as language barriers, limited health literacy, and cultural beliefs about cancer, impact refugees’ willingness and ability to seek timely care. Enabling factors, including legal status, economic constraints, and availability of refugee-specific health services, significantly shape their access to diagnosis and treatment. Although policy reforms and community-based interventions aim to improve cancer care accessibility, need-based factors, such as delays in diagnosis and inadequate continuity of care, continue to hinder optimal healthcare utilization.</div></div><div><h3>Conclusion</h3><div>To ensure more inclusive cancer care, future strategies should focus on improving healthcare system navigation, strengthening financial and structural support, and enhancing the cultural competence of healthcare professionals. A comprehensive and sustainable approach is needed to bridge gaps and promote equitable cancer care access for all refugee populations.</div></div><div><h3>Implications for Nursing Practice</h3><div>Nurses are crucial in improving cancer care for refugees by providing culturally sensitive education, enhancing communication between patients and healthcare providers, and advocating for health policies that address refugees’ specific needs. Strengthening the role of nurses in multidisciplinary teams will further enhance the delivery of holistic and patient-centered cancer care for refugees.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 3","pages":"Article 151879"},"PeriodicalIF":2.3,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}